News Center
News Center
Industry News
[2026/07/08] : AI Drug Discovery Enters Clinical Validation Era: From Technology Concept to Pharmaceutical Competition[2026/07/06] : Global “Weight-Loss Blockbuster” Enters Generic Wave as Hybio Secures FDA ANDA Acceptance[2026/07/03] : Global API Market Outlook: Industry Remains in a Cyclical Downturn While Structural Opportunities Emerge[2026/07/01] : Amoxicillin Veterinary API Market Remains Under Pressure, Prices Expected to Stay Range-Bound in the Second Half of 2026[2026/06/30] : Extreme Heat Disrupts India's Largest Ibuprofen API Plant, Raising Global Supply Chain Concerns[2026/06/28] : Sandoz Calls for EU Anti-Dumping Investigation into Chinese Amoxicillin API[2026/06/26] : Colombia Issues New Veterinary Drug Regulations, Tightens GMP Certification and Registration Requirements[2026/06/24] : API Industry Enters Downcycle: Fierce Global Competition as Executives Travel Worldwide to Secure Orders[2026/06/22] : API Industry Outlook: Innovation-Driven Growth and Global Expansion[2026/06/20] : Veterinary APIs: The Foundation of Animal Health and Food Safety[2026/06/18] : Sulfur Prices Break RMB 10,000/Ton: Titanium Dioxide Prices Surge as Coatings Industry Faces Cost Shock[2026/06/17] : APIs: China's Other Strategic Advantage in the Global Pharmaceutical Supply Chain[2026/06/15] : Beijing Unveils 2026–2030 Rural Modernization Plan to Build a RMB 10 Billion Pet Economy Cluster and Accelerate Industry Development[2026/06/13] : China Producer Price Index (PPI) Rises in May 2026, Chemical Raw Material Costs Continue to Increase[2026/06/11] : Global Pharmaceutical Industry Update: Major Multinational Companies Expand Innovation, Partnerships and Product Development in China[2026/06/09] : The 39th Meeting of Foreign-invested Veterinary Medicine Enterprises Development Symposium Held in Beijing, Focusing on Policy Alignment and International Collaboration[2026/06/07] : China Chamber of Commerce Defends Biotech Industry at U.S. ITC Hearing on Section 332 Investigation[2026/06/05] : Anglikang Expands Anti-Infective Portfolio with Two New API Approvals[2026/06/03] : China’s API Trade Review 2025: Exports Stabilize Under Pressure While Peptide Imports Surge[2026/06/01] : Takeda Loses “Pay-for-Delay” Antitrust Case: U.S. Treble Damages Could Approach $2.5 Billion
| Enter Zhuocheng | Product | Honorary Qualifications | Contact Us |
| Company IntroductionFactory Appearance | Raw materials Premixed agent product OEM products |
Company：Jinan Zhuocheng Bio-Tech Co., Ltd. Corporate email：info@zhuochengbio.com Address:Building 3, Ligao International, 1222 West Aoti Road, Lixia District, Jinan |
